Medicure Inc. (OTCMKTS:MCUJF) Short Interest Update

Medicure Inc. (OTCMKTS:MCUJF) was the recipient of a large decrease in short interest in the month of April. As of April 30th, there was short interest totaling 5,780 shares, a decrease of 50.5% from the April 15th total of 11,680 shares. Based on an average trading volume of 182 shares, the short-interest ratio is currently 31.8 days. Currently, 0.1% of the shares of the company are sold short.

Medicure Price Performance

Shares of OTCMKTS MCUJF remained flat at $0.80 during mid-day trading on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.02 and a quick ratio of 0.77. The business has a 50 day simple moving average of $0.83 and a 200-day simple moving average of $0.84. Medicure has a 1-year low of $0.68 and a 1-year high of $0.97. The firm has a market capitalization of $8.39 million, a PE ratio of -1.64 and a beta of 0.97.

Medicure (OTCMKTS:MCUJF) last released its earnings results on Thursday, April 23rd. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.25). Medicure had a negative net margin of 24.61% and a negative return on equity of 41.55%. The firm had revenue of $6.13 million during the quarter, compared to analyst estimates of $3.62 million.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.